Viatris Inc. (VTRS) News
Filter VTRS News Items
VTRS News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
VTRS News Highlights
- VTRS's 30 day story count now stands at 8.
- Over the past 20 days, the trend for VTRS's stories per day has been choppy and unclear. It has oscillated between 1 and 3.
- BEAT, COOK and DRUG are the most mentioned tickers in articles about VTRS.
Latest VTRS News From Around the Web
Below are the latest news stories about VIATRIS INC that investors may wish to consider to help them evaluate VTRS as an investment opportunity.
Regeneron Gains After Eye-Drug Patent Victory Over Viatris(Bloomberg) -- Regeneron Pharmaceuticals Inc. rose the most in almost two months after a court ruled that the drugmaker’s patent rights were infringed by a cheaper copy of its eye drug developed by Viatris Inc. Most Read from BloombergThe Late-Night Email to Tim Cook That Set the Apple Watch Saga in MotionChinese Carmaker Overtakes Tesla as World’s Most Popular EV MakerBridgewater CEO’s Past Office Romance Led to Favoritism ClaimsXiaomi Unveils Its First EV, With Ambition to Be China’s Porsche o |
Viatris to Participate in 42nd Annual J.P. Morgan Healthcare ConferenceViatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced the company will participate in the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 10, 2024. Chief Executive Officer Scott A. Smith, President Rajiv Malik and Chief Financial Officer Sanjeev Narula will represent the company in a presentation followed by a fireside chat scheduled at 10:30 a.m. PST / 1:30 p.m. ET. |
Why Investors Need to Take Advantage of These 2 Medical Stocks NowInvestors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP. |
UPDATE 1-Drugmaker Viatris appoints Theodora Mistras as CFOGlobal healthcare company Viatris on Friday appointed Theodora Mistras as its chief financial officer, effective March 1. The company said the current CFO Sanjeev Narula will work closely with Mistras to support a smooth transition and will then depart the company on March 1. Mistras most recently was the managing director of healthcare investment banking at Citigroup Global Markets and has almost two decades of leadership, advisory and capital markets experience, Viatris said. |
Viatris Continues its Preparations for Phase 2 of its Strategic Plan by Announcing the Appointment of Theodora "Doretta" Mistras as Chief Financial Officer, Effective March 1, 2024, and Philippe Martin as Chief R&D OfficerViatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that, as it prepares to enter Phase 2 of its strategic plan, Theodora "Doretta" Mistras has been appointed Chief Financial Officer (CFO) effective March 1, 2024, and Philippe Martin has been appointed Chief R&D Officer with immediate effect. |
Viatris Shareholders Re-elect All Nominated Directors and Approve All Voting Matters at Annual Meeting of ShareholdersViatris Inc. (NASDAQ: VTRS), a global healthcare company, announced that at its 2023 Annual Meeting of Shareholders held today, shareholders voted to re-elect all nominated Directors and approved/ratified all voting matters. The official voting results for each item voted on by shareholders will be disclosed in a current report on Form 8-K to be filed with the Securities and Exchange Commission. |
15 Best Undervalued Stocks To Buy Now According To The MediaIn this article, we will take a detailed look at the 15 Best Undervalued Stocks To Buy Now According to the Media. For a quick overview of such stocks, read our article 5 Best Undervalued Stocks To Buy Now According to the Media. The US stock market defied all pessimistic expectations this year and showed resilience […] |
Viatris (VTRS) Up 5.1% Since Last Earnings Report: Can It Continue?Viatris (VTRS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. |
Buy Alert: Analysts Say These 3 Growth Stocks Could Double in 2024Often the best investments are out-of-favor and trade at silly cheap valuations. |
Insider Sell Alert: President, Greater China Xiangyang Ni Sells 14,937 Shares of Viatris Inc (VTRS)In the realm of stock market movements, insider trading activity is often a significant indicator that investors keep a close eye on. |